{"id":15140,"date":"2026-02-18T18:13:13","date_gmt":"2026-02-18T17:13:13","guid":{"rendered":"https:\/\/www.future-live.com\/?page_id=15140"},"modified":"2026-11-10T15:48:49","modified_gmt":"2026-11-10T14:48:49","slug":"graminex-g63","status":"publish","type":"page","link":"https:\/\/www.future-live.com\/en\/graminex-g63\/","title":{"rendered":"Graminex\u00ae G63\u00ae"},"content":{"rendered":"

[vc_row background_color=”custom” custom_background_color=”rgba(255,255,255,0.95)”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][tm_spacer size=”lg:60″][vc_single_image image=”15065″ img_size=”full” css_animation=”none”][tm_spacer size=”lg:60″][tm_spacer size=”lg:32″][vc_column_text]<\/p>\n

\n
\n
\n
\n

Graminex\u00ae G63\u00ae<\/strong> is a standardized pollen extract obtained from rye flowers <\/strong>(Secale cereale<\/em>), known and used for years for its role in supporting prostate function<\/strong> and male urinary tract health.
\nIt is a natural ingredient, selected and processed with specific technologies that allow the extraction of an active fraction rich in bioactive components, particularly useful in helping to limit the symptoms of chronic pelvic pain associated with prostatitis<\/strong>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][tm_spacer size=”lg:60″][vc_custom_heading text=”Composition” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text]<\/p>\n

\n
\n
\n
\n

Graminex\u00ae G63\u00ae is a pollen extract that undergoes purification and microfragmentation processes to improve its bioavailability.
\nPollen is a natural source of numerous nutrients and functional compounds, including:<\/p>\n

    \n
  • amino acids and peptides<\/li>\n
  • flavonoids and phenolic compounds<\/li>\n
  • phytosterols<\/li>\n
  • enzymes and antioxidant substances<\/li>\n<\/ul>\n

    This composition makes Graminex\u00ae G63\u00ae a particularly interesting ingredient for supporting uro-prostatic conditions.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

    [\/vc_column_text][tm_spacer size=”lg:60″][vc_custom_heading text=”Mechanism of action” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text]<\/p>\n

    \n
    \n
    \n
    \n

    Prostatitis, especially in its chronic form, is a complex condition that may involve:<\/p>\n

      \n
    • persistent inflammation<\/li>\n
    • pelvic muscle tension<\/li>\n
    • microcirculatory alterations<\/li>\n
    • local nerve sensitization<\/li>\n<\/ul>\n

      Graminex\u00ae G63\u00ae may be beneficial because it acts in a multifactorial<\/strong> way, supporting the prostate and helping to improve symptoms, without being an antibiotic and without directly altering the intestinal flora.
      \nIt is often indicated especially when prostatitis is non-bacterial or when, after antibiotic therapy, irritative symptoms persist.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

      [\/vc_column_text][tm_spacer size=”lg:60″][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_custom_heading text=”Scientific studies on Graminex\u00ae G63\u00ae” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text]<\/p>\n

      \n
      \n
      \n
      \n

      Subjects with chronic pelvic pain syndrome were treated with Graminex\u00ae G63\u00ae for 12 weeks. At the end of the study, both pain intensity and overall symptom parameters were evaluated.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

      [\/vc_column_text][tm_spacer size=”lg:10″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_single_image image=”15168″ img_size=”full”][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_column_text]<\/p>\n

      \n
      \n
      \n
      \n

      This study showed that 12-week treatment with Graminex\u00ae G63\u00ae in patients with chronic pelvic pain significantly improved symptoms compared to placebo<\/strong> and was well tolerated.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

      [\/vc_column_text][tm_spacer size=”lg:80″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row background_color=”custom” custom_background_color=”rgba(0,85,153,0.8)”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][tm_spacer size=”lg:32″][vc_column_text css_animation=”fadeInDown”]Bibliografy:<\/strong><\/span>[\/vc_column_text][vc_column_text css_animation=”fadeInDown”]Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Br\u00e4hler E, Weidner W. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol. 2009 Sep;56(3):544-51. doi: 10.1016\/j.eururo.2009.05.046. Epub 2009 Jun 3. PMID: 19524353.<\/span>[\/vc_column_text][tm_spacer size=”lg:32″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row background_color=”custom” custom_background_color=”rgba(255,255,255,0.95)”][vc_column][tm_spacer size=”lg:60″][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"[vc_row background_color=”custom” custom_background_color=”rgba(255,255,255,0.95)”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][tm_spacer size=”lg:60″][vc_single_image image=”15065″ img_size=”full” css_animation=”none”][tm_spacer size=”lg:60″][tm_spacer size=”lg:32″][vc_column_text] Graminex\u00ae G63\u00ae is a standardized pollen extract obtained from rye flowers (Secale cereale), known and used for years for its role in supporting prostate function and male urinary tract health. It is a natural ingredient, selected and processed with specific technologies that allow the extraction of an active fraction rich in bioactive components, particularly useful in helping to limit the symptoms of chronic pelvic pain associated with prostatitis. [\/vc_column_text][tm_spacer size=”lg:60″][vc_custom_heading text=”Composition” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Graminex\u00ae G63\u00ae is a pollen extract that undergoes purification and microfragmentation processes to improve its bioavailability. Pollen is a natural source of numerous nutrients and functional compounds, including: amino acids and peptides flavonoids and phenolic compounds phytosterols enzymes and antioxidant substances This composition makes Graminex\u00ae G63\u00ae a particularly interesting ingredient for supporting uro-prostatic conditions. [\/vc_column_text][tm_spacer size=”lg:60″][vc_custom_heading text=”Mechanism of action” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Prostatitis, especially in its chronic form, is a complex condition that may involve: persistent inflammation pelvic muscle tension microcirculatory alterations local nerve sensitization Graminex\u00ae G63\u00ae may be beneficial because it acts in a multifactorial way, supporting the prostate and helping to improve symptoms, without being an antibiotic and without directly altering the intestinal flora. It is often indicated especially when prostatitis is non-bacterial or when, after antibiotic therapy, irritative symptoms persist. [\/vc_column_text][tm_spacer size=”lg:60″][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_custom_heading text=”Scientific studies on Graminex\u00ae G63\u00ae” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Subjects with chronic pelvic pain syndrome were treated with Graminex\u00ae G63\u00ae for 12 weeks. At the end of the study, both pain intensity and overall symptom parameters were evaluated. [\/vc_column_text][tm_spacer size=”lg:10″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_single_image image=”15168″ img_size=”full”][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_column_text] This study showed that 12-week treatment with Graminex\u00ae G63\u00ae in patients with chronic pelvic pain significantly improved symptoms compared to placebo and was well tolerated. [\/vc_column_text][tm_spacer size=”lg:80″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row background_color=”custom” custom_background_color=”rgba(0,85,153,0.8)”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][tm_spacer size=”lg:32″][vc_column_text css_animation=”fadeInDown”]Bibliografy:[\/vc_column_text][vc_column_text css_animation=”fadeInDown”]Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Br\u00e4hler E, Weidner W. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol. 2009 Sep;56(3):544-51. doi: 10.1016\/j.eururo.2009.05.046. Epub 2009 Jun 3. PMID: 19524353.[\/vc_column_text][tm_spacer size=”lg:32″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row background_color=”custom” custom_background_color=”rgba(255,255,255,0.95)”][vc_column][tm_spacer size=”lg:60″][\/vc_column][\/vc_row]","protected":false},"author":178,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"yoast_head":"\nGraminex\u00ae G63\u00ae - Future Live Srl<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.future-live.com\/en\/graminex-g63\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Graminex\u00ae G63\u00ae - Future Live Srl\" \/>\n<meta property=\"og:description\" content=\"[vc_row background_color=”custom” custom_background_color=”rgba(255,255,255,0.95)”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][tm_spacer size=”lg:60″][vc_single_image image=”15065″ img_size=”full” css_animation=”none”][tm_spacer size=”lg:60″][tm_spacer size=”lg:32″][vc_column_text] Graminex\u00ae G63\u00ae is a standardized pollen extract obtained from rye flowers (Secale cereale), known and used for years for its role in supporting prostate function and male urinary tract health. It is a natural ingredient, selected and processed with specific technologies that allow the extraction of an active fraction rich in bioactive components, particularly useful in helping to limit the symptoms of chronic pelvic pain associated with prostatitis. [\/vc_column_text][tm_spacer size=”lg:60″][vc_custom_heading text=”Composition” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Graminex\u00ae G63\u00ae is a pollen extract that undergoes purification and microfragmentation processes to improve its bioavailability. Pollen is a natural source of numerous nutrients and functional compounds, including: amino acids and peptides flavonoids and phenolic compounds phytosterols enzymes and antioxidant substances This composition makes Graminex\u00ae G63\u00ae a particularly interesting ingredient for supporting uro-prostatic conditions. [\/vc_column_text][tm_spacer size=”lg:60″][vc_custom_heading text=”Mechanism of action” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Prostatitis, especially in its chronic form, is a complex condition that may involve: persistent inflammation pelvic muscle tension microcirculatory alterations local nerve sensitization Graminex\u00ae G63\u00ae may be beneficial because it acts in a multifactorial way, supporting the prostate and helping to improve symptoms, without being an antibiotic and without directly altering the intestinal flora. It is often indicated especially when prostatitis is non-bacterial or when, after antibiotic therapy, irritative symptoms persist. [\/vc_column_text][tm_spacer size=”lg:60″][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_custom_heading text=”Scientific studies on Graminex\u00ae G63\u00ae” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Subjects with chronic pelvic pain syndrome were treated with Graminex\u00ae G63\u00ae for 12 weeks. At the end of the study, both pain intensity and overall symptom parameters were evaluated. [\/vc_column_text][tm_spacer size=”lg:10″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_single_image image=”15168″ img_size=”full”][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_column_text] This study showed that 12-week treatment with Graminex\u00ae G63\u00ae in patients with chronic pelvic pain significantly improved symptoms compared to placebo and was well tolerated. [\/vc_column_text][tm_spacer size=”lg:80″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row background_color=”custom” custom_background_color=”rgba(0,85,153,0.8)”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][tm_spacer size=”lg:32″][vc_column_text css_animation=”fadeInDown”]Bibliografy:[\/vc_column_text][vc_column_text css_animation=”fadeInDown”]Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Br\u00e4hler E, Weidner W. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol. 2009 Sep;56(3):544-51. doi: 10.1016\/j.eururo.2009.05.046. Epub 2009 Jun 3. PMID: 19524353.[\/vc_column_text][tm_spacer size=”lg:32″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row background_color=”custom” custom_background_color=”rgba(255,255,255,0.95)”][vc_column][tm_spacer size=”lg:60″][\/vc_column][\/vc_row]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.future-live.com\/en\/graminex-g63\/\" \/>\n<meta property=\"og:site_name\" content=\"Future Live Srl\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FutureLivesrl\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-10T14:48:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.future-live.com\/en\/graminex-g63\/\",\"url\":\"https:\/\/www.future-live.com\/en\/graminex-g63\/\",\"name\":\"Graminex\u00ae G63\u00ae - Future Live Srl\",\"isPartOf\":{\"@id\":\"https:\/\/www.future-live.com\/#website\"},\"datePublished\":\"2026-02-18T17:13:13+00:00\",\"dateModified\":\"2026-11-10T14:48:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.future-live.com\/en\/graminex-g63\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.future-live.com\/en\/graminex-g63\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.future-live.com\/en\/graminex-g63\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.future-live.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Graminex\u00ae G63\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.future-live.com\/#website\",\"url\":\"https:\/\/www.future-live.com\/\",\"name\":\"Future Live Srl\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.future-live.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.future-live.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.future-live.com\/#organization\",\"name\":\"Future Live\",\"url\":\"https:\/\/www.future-live.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png\",\"contentUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png\",\"width\":1428,\"height\":1315,\"caption\":\"Future Live\"},\"image\":{\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/FutureLivesrl\/\",\"https:\/\/www.linkedin.com\/company\/future-live-srl\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Graminex\u00ae G63\u00ae - Future Live Srl","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.future-live.com\/en\/graminex-g63\/","og_locale":"en_US","og_type":"article","og_title":"Graminex\u00ae G63\u00ae - Future Live Srl","og_description":"[vc_row background_color=”custom” custom_background_color=”rgba(255,255,255,0.95)”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][tm_spacer size=”lg:60″][vc_single_image image=”15065″ img_size=”full” css_animation=”none”][tm_spacer size=”lg:60″][tm_spacer size=”lg:32″][vc_column_text] Graminex\u00ae G63\u00ae is a standardized pollen extract obtained from rye flowers (Secale cereale), known and used for years for its role in supporting prostate function and male urinary tract health. It is a natural ingredient, selected and processed with specific technologies that allow the extraction of an active fraction rich in bioactive components, particularly useful in helping to limit the symptoms of chronic pelvic pain associated with prostatitis. [\/vc_column_text][tm_spacer size=”lg:60″][vc_custom_heading text=”Composition” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Graminex\u00ae G63\u00ae is a pollen extract that undergoes purification and microfragmentation processes to improve its bioavailability. Pollen is a natural source of numerous nutrients and functional compounds, including: amino acids and peptides flavonoids and phenolic compounds phytosterols enzymes and antioxidant substances This composition makes Graminex\u00ae G63\u00ae a particularly interesting ingredient for supporting uro-prostatic conditions. [\/vc_column_text][tm_spacer size=”lg:60″][vc_custom_heading text=”Mechanism of action” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Prostatitis, especially in its chronic form, is a complex condition that may involve: persistent inflammation pelvic muscle tension microcirculatory alterations local nerve sensitization Graminex\u00ae G63\u00ae may be beneficial because it acts in a multifactorial way, supporting the prostate and helping to improve symptoms, without being an antibiotic and without directly altering the intestinal flora. It is often indicated especially when prostatitis is non-bacterial or when, after antibiotic therapy, irritative symptoms persist. [\/vc_column_text][tm_spacer size=”lg:60″][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_custom_heading text=”Scientific studies on Graminex\u00ae G63\u00ae” font_container=”tag:h2|font_size:30|text_align:left” use_theme_fonts=”yes”][tm_spacer size=”lg:32″][vc_column_text] Subjects with chronic pelvic pain syndrome were treated with Graminex\u00ae G63\u00ae for 12 weeks. At the end of the study, both pain intensity and overall symptom parameters were evaluated. [\/vc_column_text][tm_spacer size=”lg:10″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_single_image image=”15168″ img_size=”full”][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_column_text] This study showed that 12-week treatment with Graminex\u00ae G63\u00ae in patients with chronic pelvic pain significantly improved symptoms compared to placebo and was well tolerated. [\/vc_column_text][tm_spacer size=”lg:80″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row background_color=”custom” custom_background_color=”rgba(0,85,153,0.8)”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][tm_spacer size=”lg:32″][vc_column_text css_animation=”fadeInDown”]Bibliografy:[\/vc_column_text][vc_column_text css_animation=”fadeInDown”]Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Br\u00e4hler E, Weidner W. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol. 2009 Sep;56(3):544-51. doi: 10.1016\/j.eururo.2009.05.046. Epub 2009 Jun 3. PMID: 19524353.[\/vc_column_text][tm_spacer size=”lg:32″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row background_color=”custom” custom_background_color=”rgba(255,255,255,0.95)”][vc_column][tm_spacer size=”lg:60″][\/vc_column][\/vc_row]","og_url":"https:\/\/www.future-live.com\/en\/graminex-g63\/","og_site_name":"Future Live Srl","article_publisher":"https:\/\/www.facebook.com\/FutureLivesrl\/","article_modified_time":"2026-11-10T14:48:49+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.future-live.com\/en\/graminex-g63\/","url":"https:\/\/www.future-live.com\/en\/graminex-g63\/","name":"Graminex\u00ae G63\u00ae - Future Live Srl","isPartOf":{"@id":"https:\/\/www.future-live.com\/#website"},"datePublished":"2026-02-18T17:13:13+00:00","dateModified":"2026-11-10T14:48:49+00:00","breadcrumb":{"@id":"https:\/\/www.future-live.com\/en\/graminex-g63\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.future-live.com\/en\/graminex-g63\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.future-live.com\/en\/graminex-g63\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.future-live.com\/en\/"},{"@type":"ListItem","position":2,"name":"Graminex\u00ae G63\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.future-live.com\/#website","url":"https:\/\/www.future-live.com\/","name":"Future Live Srl","description":"","publisher":{"@id":"https:\/\/www.future-live.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.future-live.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.future-live.com\/#organization","name":"Future Live","url":"https:\/\/www.future-live.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png","contentUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png","width":1428,"height":1315,"caption":"Future Live"},"image":{"@id":"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FutureLivesrl\/","https:\/\/www.linkedin.com\/company\/future-live-srl\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/pages\/15140"}],"collection":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/users\/178"}],"replies":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/comments?post=15140"}],"version-history":[{"count":1,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/pages\/15140\/revisions"}],"predecessor-version":[{"id":16811,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/pages\/15140\/revisions\/16811"}],"wp:attachment":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/media?parent=15140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}